Trade BFRIW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Biofrontera Inc. Warrants (BFRIW) is trading at US$0.02, up 0.00% today as of Sep 18, 16:00 EDT. Over the past 52 weeks, BFRIW has traded between US$0.02 and US$0.15. On Syfe you can trade BFRIW with $0 commission and add it to your watchlist.
| Previous close | US$0.02 |
|---|---|
| 52-week range | US$0.02 – US$0.15 |
| Volume | 3.67K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Biofrontera Inc. Warrants
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
Year: 2021
Biofrontera Inc. Warrants (BFRIW) stock is trading at US$0.02, 0.00% from the previous close of US$0.02.
The 52-week high for Biofrontera Inc. Warrants (BFRIW) stock is US$0.15.
The 52-week low for Biofrontera Inc. Warrants (BFRIW) stock is US$0.02.
Biofrontera Inc. Warrants (BFRIW) does not currently pay a dividend.
Stay on top of BFRIW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
